Clinical Trial Update: Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Triamcinolone acetonide injections for diabetic macular edema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Diabetic Retinopathy | Phase 2 | Status: COMPLETED